InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,579.64
(
-0.96%
)
US TECH 100
19,714.80
(
-2.01%
)
Dow Jones
39,753.20
(
0.08%
)
Brent Oil
84.95
(
-0.12%
)
Bitcoin
57,929.89
(
0.29%
)
Post# of 252571
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

flatlander_60048

Send PM Follow Ignore
Followers 10
Posts 477
Boards Moderated 0
Alias Born 02/10/2006

flatlander_60048

Re: DewDiligence post# 109658

Tuesday, 11/30/2010 11:25:26 PM

Tuesday, November 30, 2010 11:25:26 PM

Post# of 252571
Besides the patent expiration reasons stated, it is apparent that the sales staff needs to be commensurate with market opportunities. The US is becoming a relatively stagnant Pharma market. I think NVS felt that a streamlined sales force could function fine and that global resources were best directed to faster growing markets.

FL
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up